Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis

The similarity between originator and biosimilar monoclonal antibody candidates are rigorously assessed based on primary, secondary, tertiary, quaternary structures, and biological functions. Minor differences in such parameters may alter target-binding, potency, efficacy, or half-life of the molecule. The charge heterogeneity analysis is a prerequisite for all biotherapeutics. Monoclonal antibodies are prone to enzymatic or non-enzymatic structural modifications during or after the production processes, leading to the formation of fragments or aggregates, various glycoforms, oxidized, deamidated, and other degraded residues, reduced Fab region binding activity or altered FcR binding activity. Therefore, the charge variant profiles of the monoclonal antibodies must be regularly and thoroughly evaluated. Comparative structural and functional analysis of physically separated or fractioned charged variants of monoclonal antibodies has gained significant attention in the last few years. The fraction-based charge variant analysis has proved very useful for the biosimilar candidates comprising of unexpected charge isoforms. In this report, the key methods for the physical separation of monoclonal antibody charge variants, structural and functional analyses by liquid chromatographymass spectrometry, and surface plasmon resonance techniques were reviewed. (c) 2021 Elsevier B.V. All rights reserved.

Automated summary

This article rigorously assesses the similarity between originator and biosimilar monoclonal antibodies, emphasizing the importance of charge variant analysis and its necessity for biotherapeutics. Comparative structural and functional analysis, along with techniques such as liquid chromatography-mass spectrometry and surface plasmon resonance, can effectively evaluate and validate the charge variants of monoclonal antibodies.